Literature DB >> 15988556

Decreased bone mineral density in patients with neurofibromatosis 1.

Marga Lammert, Martin Kappler, Victor-Felix Mautner, Kurt Lammert, Stephan Störkel, Jan M Friedman, Derek Atkins.   

Abstract

Neurofibromatosis 1 (NF1) is one of the most common autosomal dominant diseases. Although there is a considerable variability in clinical expression, NF1 is almost fully penetrant in adult patients and may be associated with a variety of skeletal anomalies. Spinal deformities are the most common skeletal manifestation, with an incidence estimated from 10-25% in various studies. Some NF1 patients have a dystrophic form of scoliosis, which is characterized by early age at onset and rapid progression. Complications have been reported during spinal instrumentation of dystrophic curves due to soft, non-resistant vertebral bony tissue, suggesting that an alteration of bone quality may occur in NF1 patients. Recent studies have suggested that decreased bone mineral density (BMD) may occur among patients with NF1. We performed a cross-sectional study on 104 adults with NF1, using quantitative ultrasonometry (QUS) to investigate whether decreased BMD is a general phenomenon in NF1 patients. The data reveal that BMD, as measured by age- and gender- adjusted Z-scores, is significantly lower in NF1 patients than in the normal reference population. The decrease in BMD appears to be even more marked among NF1 patients with scoliosis that requires surgical treatment. The findings indicate that NF1 produces a generalized alteration of bone in addition to the focal osseous dysplasias of the vertebrae, tibia, and sphenoid wing that characterize this condition. The pathological mechanism underlying these bony changes remains to be elucidated.

Entities:  

Mesh:

Year:  2005        PMID: 15988556     DOI: 10.1007/s00198-005-1940-2

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  26 in total

1.  Comparison of ultrasound and dual energy X-ray absorptiometry measurements in the calcaneus.

Authors:  C Kang; R Speller
Journal:  Br J Radiol       Date:  1998-08       Impact factor: 3.039

2.  Acute and subacute changes in the ultrasound measurements of the calcaneus following intense exercise.

Authors:  K L Bennell; P Hart; C Nattrass; J D Wark
Journal:  Calcif Tissue Int       Date:  1998-12       Impact factor: 4.333

3.  Patterns of physical activity and ultrasound attenuation by heel bone among Norfolk cohort of European Prospective Investigation of Cancer (EPIC Norfolk): population based study.

Authors:  R W Jakes; K Khaw; N E Day; S Bingham; A Welch; S Oakes; R Luben; N Dalzell; J Reeve; N J Wareham
Journal:  BMJ       Date:  2001-01-20

4.  Pathology of bone lesions associated with congenital pseudarthrosis of the leg.

Authors:  E Ippolito; A Corsi; F Grill; S Wientroub; P Bianco
Journal:  J Pediatr Orthop B       Date:  2000-01       Impact factor: 1.041

5.  Congenital pseudarthrosis of the tibia: history, etiology, classification, and epidemiologic data.

Authors:  F Hefti; G Bollini; P Dungl; J Fixsen; F Grill; E Ippolito; B Romanus; C Tudisco; S Wientroub
Journal:  J Pediatr Orthop B       Date:  2000-01       Impact factor: 1.041

6.  Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients.

Authors:  J M Friedman; P H Birch
Journal:  Am J Med Genet       Date:  1997-05-16

7.  Adult hypophosphataemic osteomalacia with Fanconi syndrome presenting in a patient with neurofibromatosis.

Authors:  J Lambert; P Lips
Journal:  Neth J Med       Date:  1989-12       Impact factor: 1.422

8.  BRD2 (RING3) is a probable major susceptibility gene for common juvenile myoclonic epilepsy.

Authors:  Deb K Pal; Oleg V Evgrafov; Paula Tabares; Fengli Zhang; Martina Durner; David A Greenberg
Journal:  Am J Hum Genet       Date:  2003-06-25       Impact factor: 11.025

9.  Identification and characterization of the neurofibromatosis type 1 protein product.

Authors:  J E DeClue; B D Cohen; D R Lowy
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

10.  Age-associated changes in bone ultrasonometry of the os calcis.

Authors:  Peyman Hadji; Mathias Kalder; J Backhus; May Gottschalk; Olaf Hars; Klaus-Deiter Schulz
Journal:  J Clin Densitom       Date:  2002       Impact factor: 2.963

View more
  42 in total

Review 1.  When Low Bone Mineral Density and Fractures Is Not Osteoporosis.

Authors:  Smita Jha; Marquis Chapman; Kelly Roszko
Journal:  Curr Osteoporos Rep       Date:  2019-10       Impact factor: 5.096

2.  Activating transcription factor 4 regulates osteoclast differentiation in mice.

Authors:  Huiling Cao; Shibing Yu; Zhi Yao; Deborah L Galson; Yu Jiang; Xiaoyan Zhang; Jie Fan; Binfeng Lu; Youfei Guan; Min Luo; Yumei Lai; Yibei Zhu; Noriyoshi Kurihara; Kenneth Patrene; G David Roodman; Guozhi Xiao
Journal:  J Clin Invest       Date:  2010-07-12       Impact factor: 14.808

3.  Bone resorption in syndromes of the Ras/MAPK pathway.

Authors:  D A Stevenson; E L Schwarz; J C Carey; D H Viskochil; H Hanson; S Bauer; H-Y Cindy Weng; T Greene; K Reinker; J Swensen; R J Chan; F-C Yang; L Senbanjo; Z Yang; R Mao; M Pasquali
Journal:  Clin Genet       Date:  2011-01-19       Impact factor: 4.438

4.  ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae.

Authors:  Florent Elefteriou; M Douglas Benson; Hideaki Sowa; Michael Starbuck; Xiuyun Liu; David Ron; Luis F Parada; Gerard Karsenty
Journal:  Cell Metab       Date:  2006-12       Impact factor: 27.287

5.  Hyperactivation of p21ras and PI3K cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions.

Authors:  Feng-Chun Yang; Shi Chen; Alexander G Robling; Xijie Yu; Todd D Nebesio; Jincheng Yan; Trent Morgan; Xiaohong Li; Jin Yuan; Janet Hock; David A Ingram; D Wade Clapp
Journal:  J Clin Invest       Date:  2006-10-19       Impact factor: 14.808

6.  Nf1 Haploinsufficiency Alters Myeloid Lineage Commitment and Function, Leading to Deranged Skeletal Homeostasis.

Authors:  Steven D Rhodes; Hao Yang; Ruizhi Dong; Keshav Menon; Yongzheng He; Zhaomin Li; Shi Chen; Karl W Staser; Li Jiang; Xiaohua Wu; Xianlin Yang; Xianghong Peng; Khalid S Mohammad; Theresa A Guise; Mingjiang Xu; Feng-Chun Yang
Journal:  J Bone Miner Res       Date:  2015-05-21       Impact factor: 6.741

7.  Males with familial idiopathic scoliosis: a distinct phenotypic subgroup.

Authors:  Mark Clough; Cristina M Justice; Beth Marosy; Nancy H Miller
Journal:  Spine (Phila Pa 1976)       Date:  2010-01-15       Impact factor: 3.468

8.  Hyperactive transforming growth factor-β1 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse model.

Authors:  Steven D Rhodes; Xiaohua Wu; Yongzheng He; Shi Chen; Hao Yang; Karl W Staser; Jiapeng Wang; Ping Zhang; Chang Jiang; Hiroki Yokota; Ruizhi Dong; Xianghong Peng; Xianlin Yang; Sreemala Murthy; Mohamad Azhar; Khalid S Mohammad; Mingjiang Xu; Theresa A Guise; Feng-Chun Yang
Journal:  J Bone Miner Res       Date:  2013-12       Impact factor: 6.741

Review 9.  Neurofibromatosis type 1.

Authors:  Kevin P Boyd; Bruce R Korf; Amy Theos
Journal:  J Am Acad Dermatol       Date:  2009-07       Impact factor: 11.527

10.  Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice.

Authors:  Richa Sharma; Xiaohua Wu; Steven D Rhodes; Shi Chen; Yongzheng He; Jin Yuan; Jiliang Li; Xianlin Yang; Xiaohong Li; Li Jiang; Edward T Kim; David A Stevenson; David Viskochil; Mingjiang Xu; Feng-Chun Yang
Journal:  Hum Mol Genet       Date:  2013-07-17       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.